tradingkey.logo

Outset Medical Inc

OM

14.170USD

+0.240+1.72%
Close 09/18, 16:00ETQuotes delayed by 15 min
251.74MMarket Cap
LossP/E TTM

Outset Medical Inc

14.170

+0.240+1.72%
More Details of Outset Medical Inc Company
Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
Company Info
Ticker SymbolOM
Company nameOutset Medical Inc
IPO dateSep 15, 2020
CEOMs. Leslie L. Trigg
Number of employees354
Security typeOrdinary Share
Fiscal year-endSep 15
Address3052 Orchard Drive
CitySAN JOSE
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code95134
Phone16692318200
Websitehttps://outsetmedical.com/
Ticker SymbolOM
IPO dateSep 15, 2020
CEOMs. Leslie L. Trigg
Company Executives
Name
Name/Position
Position
Shareholding
Change
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
68.32K
-1.31%
Mr. Marc Nash
Mr. Marc Nash
Senior Vice President - Operations and Research and Development
Senior Vice President - Operations and Research and Development
40.63K
+15.24%
Mr. Patrick T. (Pat) Hackett
Mr. Patrick T. (Pat) Hackett
Independent Director
Independent Director
22.95K
+64.31%
Mr. Brent D. Lang
Mr. Brent D. Lang
Independent Director
Independent Director
10.25K
+706.77%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
9.22K
+3711.98%
Mrs. Brittni Mcgill
Mrs. Brittni Mcgill
Chief Nursing Officer
Chief Nursing Officer
--
--
Mr. John L. Brottem
Mr. John L. Brottem
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. D. Keith Grossman
Mr. D. Keith Grossman
Lead Independent Director
Lead Independent Director
--
--
Ms. Andrea L. Saia
Ms. Andrea L. Saia
Independent Director
Independent Director
--
--
Ms. Renee M. Gaeta, CPA
Ms. Renee M. Gaeta, CPA
Chief Financial Officer
Chief Financial Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
68.32K
-1.31%
Mr. Marc Nash
Mr. Marc Nash
Senior Vice President - Operations and Research and Development
Senior Vice President - Operations and Research and Development
40.63K
+15.24%
Mr. Patrick T. (Pat) Hackett
Mr. Patrick T. (Pat) Hackett
Independent Director
Independent Director
22.95K
+64.31%
Mr. Brent D. Lang
Mr. Brent D. Lang
Independent Director
Independent Director
10.25K
+706.77%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
9.22K
+3711.98%
Mrs. Brittni Mcgill
Mrs. Brittni Mcgill
Chief Nursing Officer
Chief Nursing Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Consumables
14.20M
47.74%
Services and other revenue
8.46M
28.43%
Consoles
7.09M
23.83%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Consumables
14.20M
47.74%
Services and other revenue
8.46M
28.43%
Consoles
7.09M
23.83%
Shareholding Stats
Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
14.47%
PFM Health Sciences, LP
9.37%
Durable Capital Partners LP
9.33%
T. Rowe Price Investment Management, Inc.
9.14%
Alyeska Investment Group, L.P.
8.24%
Other
49.45%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
14.47%
PFM Health Sciences, LP
9.37%
Durable Capital Partners LP
9.33%
T. Rowe Price Investment Management, Inc.
9.14%
Alyeska Investment Group, L.P.
8.24%
Other
49.45%
Shareholder Types
Shareholders
Proportion
Hedge Fund
42.85%
Investment Advisor
39.48%
Investment Advisor/Hedge Fund
13.45%
Private Equity
4.69%
Individual Investor
2.10%
Research Firm
1.52%
Venture Capital
1.00%
Corporation
0.63%
Bank and Trust
0.34%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
348
16.26M
91.74%
+11.98M
2025Q1
363
14.91M
84.25%
+11.40M
2024Q4
375
22.97M
42.67%
-34.22M
2024Q3
383
28.58M
54.40%
-41.22M
2024Q2
397
50.60M
97.17%
-19.65M
2024Q1
406
52.26M
101.52%
-18.15M
2023Q4
416
54.21M
107.73%
-7.17M
2023Q3
407
56.98M
114.62%
-11.76M
2023Q2
399
56.04M
113.10%
-11.31M
2023Q1
408
55.02M
111.94%
-9.31M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
2.58M
14.55%
+2.35M
+1040.39%
Mar 31, 2025
PFM Health Sciences, LP
1.69M
9.51%
+1.69M
--
Mar 31, 2025
Durable Capital Partners LP
1.74M
9.82%
+1.74M
--
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
1.60M
9.05%
+1.39M
+659.32%
Mar 31, 2025
Alyeska Investment Group, L.P.
1.70M
9.61%
+1.70M
--
Mar 31, 2025
Woodline Partners LP
1.33M
7.48%
+1.33M
--
Mar 31, 2025
The Vanguard Group, Inc.
173.32K
0.98%
-602.00
-0.35%
Mar 31, 2025
Perceptive Advisors LLC
833.33K
4.7%
+833.33K
--
Mar 31, 2025
MFS Investment Management
840.25K
4.74%
+840.25K
--
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
Date
Type
Ratio
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
KeyAI